The TPP could give pharmaceutical corporations more power to control medicine markets and “impose higher prices for longer.”
The lack of access to details in the text means governments can put a positive spin on the deal, but the devil is in the detail.
Australia — along with others such as New Zealand and Chile — has been unwilling to offer more than five years protection for the medicines, because longer terms would increase the cost of state-subsidised medical programs.
Countries in the trade bloc would have an alternative of either providing eight years of exclusivity to biologic drugs, or providing five years of so-called data exclusivity plus up to three more years under a regulatory framework in the TPP.
A standoff between Australia and the United States on monopoly rules for
pharmaceutical drugs has emerged as the ultimate impediment to clinching an
historic trade deal sweeping across 12 Pacific Rim countries.
The latest round of trade talks between Taiwan and the U.S. under the bilateral Trade and Investment Framework Agreement (TIFA) made much ground in a number of areas but both sides have yet to reach consensus on issues such as U.S. pork imports.
The latest round of Trade and Investment Framework Agreement (TIFA) talks with the US ignores the interests of ordinary citizens, labor activists said yesterday.
The talks remained bogged down after two days of negotiations between ministers from the United States, Japan, Australia and nine other countries over a handful of sticky issues.
Les représentants de 12 pays riverains du Pacifique se réunissent à Atlanta pour tenter de parvenir à une entente sur un vaste accord commercial, connu sous son acronyme TPP.
Major challenges in three areas remain in concluding the Trans-Pacific Partnership, according to officials involved in the discussions.
Arrested from hotel demanding to see the secret "death sentence clause"
Despite the deep irony of free trade agreements being subverted to codify and extend anti-competitive monopoly rights the joining of enhanced intellectual property rights (IPRs) and strengthened investor rights is creating a wild-west opportunity for unbounded corporate power.
Most free trade agreements signed by the United States, the European Union and the members of the European Free Trade Association (EFTA) contain chapters on intellectual property rights that expand the rights recognized to pharmaceutical companies.
Médecins Sans Frontières/Doctors Without Borders (MSF) warned that US pressure for India to change its intellectual property policies could result in millions of people around the world losing their lifeline of affordable medicines.
The top members of US Congress and the Senate responsible for international trade issues urged the Obama administration to push for changes to India’s handling of intellectual property rights and technology
The Whanganui District Health Board has acknowledged a letter sent to Dr Chris Cresswell expressing concerns over his views on the Trans-Pacific Partnership was "inappropriate", the Association of Salaried Medical Specialists says.
A doctor who jumped on a car carrying the deputy prime minister during a TPP protest and had to be forcibly removed could lose his job.
While RCEP was initially framed as an agreement that would be more flexible for low and middle income countries, there is evidence that some governments from industrialised countries are seeking to pursue aspects which would be very damaging for developing countries.
Less well known than the notorious Trans-Pacific Partnership, the Regional Comprehensive Economic Partnership (RCEP) is engendering growing opposition because of its similar oppressive provisions.
Joseph Stiglitz, the Nobel Prize-winning economist, discusses TPP.